Figure - available from: Journal of Population Research
This content is subject to copyright. Terms and conditions apply.
Smooth density functions describing the age-at-death distribution for leading causes of death among elderly U.S. males and females aged 10 and above, for calendar years 1974 (thin line), 1993 (medium line), and 2011 (thick line). Source: Authors’ calculations based on the U.S. National Vital Statistics System data files, and Human Mortality Database
Source publication
The U.S. elderly experience shorter lifespans and greater variability in age at death than their Canadian peers. In order to gain insight on the underlying factors responsible for the Canada-U.S. old-age mortality disparities, we propose a cause-of-death analysis. Accordingly, the objective of this paper is to compare levels and trends in cause-spe...
Similar publications
Objectives
To determine outcomes in rheumatoid arthritis with long-term analysis of a real-world inception cohort
Methods
Retrospective cohort analysis of 184 patients with new diagnosis of RA (ACR/EULAR 2010 criteria) between 2009 & 2013. Measured parameters include patient demographics, serological markers, disease activity (DAS28-CRP), treatmen...
Citations
The health problems associated with the aging process are becoming increasingly widespread due to the increase in mean life expectancy taking place globally. While decline of many organ functions is an unavoidable concomitant of senescence, these can be delayed or moderated by a range of factors. Among these are dietary changes and weight control, taking sufficient exercise, and the utilization of various micronutrients. The utility of incurring appropriate changes in lifestyle is generally not confined to a single organ system but has a broadly positive systemic effect.Among one of the most potent means of slowing down age-related changes is the use of melatonin, a widely distributed biological indole. While melatonin is well known as a treatment for insomnia, it has a wide range of beneficial qualities many of which are relevant. This overview describes how several of the properties of melatonin are especially relevant to many of the changes associated with senescence. Changes in functioning of the immune system are particularly marked in the aged, combining diminishing effectiveness with increasing ineffective and harmful activity. Melatonin treatment appears able to moderate and partially reverse this detrimental drift toward immune incompetence.KeywordsMelatoninCancerCardiac diseaseCerebrovascular diseaseDiabetesFrailtyImmune competenceReceptor activationSARS-CoV-2